{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T14:26:20Z","timestamp":1747232780598,"version":"3.40.5"},"reference-count":36,"publisher":"Korean College of Neuropsychopharmacology","issue":"2","license":[{"start":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T00:00:00Z","timestamp":1622419200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["www.cpn.or.kr"],"crossmark-restriction":true},"short-container-title":["Clin Psychopharmacol Neurosci"],"published-print":{"date-parts":[[2021,5,31]]},"DOI":"10.9758\/cpn.2021.19.2.355","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T08:20:10Z","timestamp":1619166010000},"page":"355-360","update-policy":"https:\/\/doi.org\/10.9758\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effect of Varenicline on Tardive Dyskinesia: A Pilot Study"],"prefix":"10.9758","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2840-4763","authenticated-orcid":false,"given":"Stanley N.","family":"Caroff","sequence":"first","affiliation":[{"name":"Behavioral Health Service, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, USA"},{"name":"Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4231-9090","authenticated-orcid":false,"given":"Alisa R.","family":"Gutman","sequence":"additional","affiliation":[{"name":"Behavioral Health Service, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8676-8907","authenticated-orcid":false,"given":"John","family":"Northrop","sequence":"additional","affiliation":[{"name":"Behavioral Health Service, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2161-3466","authenticated-orcid":false,"given":"Shirley H.","family":"Leong","sequence":"additional","affiliation":[{"name":"Behavioral Health Service, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8828-6845","authenticated-orcid":false,"given":"Rosalind M.","family":"Berkowitz","sequence":"additional","affiliation":[{"name":"Behavioral Health Service, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8198-2493","authenticated-orcid":false,"given":"E. Cabrina","family":"Campbell","sequence":"additional","affiliation":[{"name":"Behavioral Health Service, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, USA"},{"name":"Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4713","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2018.02.004"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.09m05793yel"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.9758\/cpn.2020.18.2.322"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-018-0105-0"},{"key":"ref5","unstructured":"Jeste DV, Lohr JB, Kauffmann CA, Wyatt RJ. Pathophysiology of tardive dyskinesia; Evaluation of supersensitivity theory and alternative hypothesis. In: Casey DE, Gardos G, editors. Tardive dyskinesia and neuroleptics: from dogma to reason. Washington, D.C.:American Psychiatric Press;1986. p.15-32."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/070674370505000907"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25909"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Conti MM, Chambers N, Bishop C. A new outlook on cholinergic interneurons in Parkinson\u2019s disease and L-DOPA-induced dyskinesia. Neurosci Biobehav Rev 2018;92:67-82.","DOI":"10.1016\/j.neubiorev.2018.05.021"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(93)90044-e"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2017.1358616"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v62n1004"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000204.pub2"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v68n0309"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fnana.2011.00006"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Bordia T, Hrachova M, Chin M, McIntosh JM, Quik M. Varenicline is a potent partial agonist at a6b2* nicotinic acetylcholine receptors in rat and monkey striatum. J Pharmacol Exp Ther 2012;342:327-334.","DOI":"10.1124\/jpet.112.194852"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/nty063"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Quik M, Bordia T, Zhang D, Perez XA. Nicotine and nicotinic receptor drugs: potential for Parkinson\u2019s disease and drug-induced movement disorders. Int Rev Neurobiol 2015;124:247-271.","DOI":"10.1016\/bs.irn.2015.07.005"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.111.189100"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001015"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2011.238"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0143490"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.11m07522"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000328"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2174\/1874205X01509010007"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.149.9.1189"},{"key":"ref26","unstructured":"George TP, Vessicchio JC, Termine A. Nicotine and tabacco use in schizophrenia. Medical illness and schizophrenia. Arlington:American Psychiatric Publishing, Inc;2003. p.81-98."},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1177\/0091270009343694"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2008.07.007"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Glazer WM, Morgenstern H, Doucette JT. Predicting the long-term risk of tardive dyskinesia in outpatients maintained on neuroleptic medications. J Clin Psychiatry 1993;54:133-139.","DOI":"10.1001\/archpsyc.1993.01820210057007"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Guy W. Abnormal Involuntary Movement Scale (II7-AIMS). In: Guy W, editor. ECDEU assessment manual for psycho-pharmacology. Rockville:Alcohol Drug Abuse and Mental Health Administration;1976. p.534-537.","DOI":"10.1037\/e591322011-001"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Brown RA, Burgess ES, Sales DS, Whiteley JA, Evans DM, Miller IW. Reliability and validity of a smoking timeline follow-back interview. Psychol Addict Behav 1998;12:101-112.","DOI":"10.1037\/0893-164X.12.2.101"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1970.tb02066.x"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.154.5.672"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psy.51.1.80"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2016.12.016"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.9758\/cpn.2017.15.2.194"}],"container-title":["Clinical Psychopharmacology and Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/pdf.medrang.co.kr\/CPN2\/2021\/019\/cpn019-02-17.pdf","content-type":"unspecified","content-version":"tdm","intended-application":"text-mining"},{"URL":"http:\/\/pdf.medrang.co.kr\/CPN2\/2021\/019\/cpn019-02-17.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T02:48:09Z","timestamp":1620614889000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cpn.or.kr\/journal\/view.html?doi=10.9758\/cpn.2021.19.2.355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,31]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,5,31]]}},"alternative-id":["10.9758\/cpn.2021.19.2.355"],"URL":"https:\/\/doi.org\/10.9758\/cpn.2021.19.2.355","relation":{},"ISSN":["1738-1088","2093-4327"],"issn-type":[{"type":"print","value":"1738-1088"},{"type":"electronic","value":"2093-4327"}],"subject":[],"published":{"date-parts":[[2021,5,31]]},"assertion":[{"value":"http:\/\/www.cpn.or.kr\/journal\/view.html?doi=10.9758\/cpn.2021.19.2.355","URL":"http:\/\/www.cpn.or.kr\/journal\/view.html?doi=10.9758\/cpn.2021.19.2.355","name":"the_journal","label":"Clin Psychopharmacol Neurosci","group":{"name":"multiple_resolution","label":"Full text available at:"}},{"value":"2020-07-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-31","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}},{"value":"https:\/\/orcid.org\/0000-0003-2840-4763","URL":"https:\/\/orcid.org\/0000-0003-2840-4763","name":"author","label":"Stanley N. Caroff","group":{"name":"orcid","label":"ORCID"}},{"value":"https:\/\/orcid.org\/0000-0002-4231-9090","URL":"https:\/\/orcid.org\/0000-0002-4231-9090","name":"author","label":"Alisa R. Gutman","group":{"name":"orcid","label":"ORCID"}},{"value":"https:\/\/orcid.org\/0000-0001-8676-8907","URL":"https:\/\/orcid.org\/0000-0001-8676-8907","name":"author","label":"John Northrop","group":{"name":"orcid","label":"ORCID"}},{"value":"https:\/\/orcid.org\/0000-0003-2161-3466","URL":"https:\/\/orcid.org\/0000-0003-2161-3466","name":"author","label":"Shirley H. Leong","group":{"name":"orcid","label":"ORCID"}},{"value":"https:\/\/orcid.org\/0000-0002-8828-6845","URL":"https:\/\/orcid.org\/0000-0002-8828-6845","name":"author","label":"Rosalind M. Berkowitz","group":{"name":"orcid","label":"ORCID"}},{"value":"https:\/\/orcid.org\/0000-0002-8198-2493","URL":"https:\/\/orcid.org\/0000-0002-8198-2493","name":"author","label":"E. Cabrina Campbell","group":{"name":"orcid","label":"ORCID"}},{"value":"\u00a9 2021 The Korean College of Neuropsychopharmacology","name":"copyright","label":"Copyright","group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:\/\/creativecommons.org\/licenses\/by-nc\/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.","name":"license","label":"License","explanation":{"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},"group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}}]}}